Unlock the future of CNS treatment

Join our team of Innovators

Avanir employees are a diverse team of dedicated, accomplished professionals united by a common purpose: striving to make a change by developing innovative treatments for central nervous system (CNS) conditions.

​
Avanir Pharmaceuticals, Inc. an indirect subsidiary of Otsuka Holdings Co., Ltd., announced Friday, January 19, that the latter has signed the CEO Statement of Support for the Women’s Empowerment Principles (WEPs), a set of Principles focusing on corporate action to promote gender

According to a new report, the amount of American lives altered by Alzheimer’s disease (AD) continues to grow. Researchers discovered that roughly 5+ million Americans had Alzheimer’s or mild cognitive impairment (MCI) as a result of the disease in 2017. The report also revealed that 16 million

We vehemently oppose any mischaracterization of how Avanir and other members of the pharmaceutical industry interact with the medical community, including physicians that educate other health care professionals about medicines. Patients and doctors want options for treatment and

We stand proudly by our commitment to research and development of treatments for CNS disorders and our relationships with advocacy organizations in our overarching commitment to help and support these patients and care communities. Our donations and support assist these organizations in

PBA is a neurological condition that affects up to an estimated 2 million Americans, but can be misunderstood by patients and their families. When someone with PBA has an intense laughing or crying episode, he or she can feel powerless, embarrassed, or discomforted. PBA occurs in people who already

In this interview with Modern Counsel magazine, Avanir VP and General Counsel Garlan Adams shares her thoughts on how the biotechnology and pharmaceutical industry is transforming disease treatment. Based on her 18 years of industry experience, Garlan describes the challenges of the drug

A portion of our activities dedicated to reducing bias among the general public about nerve and mental diseases has won the Bronze for the Pharma category of Lions Health at the 63rd Cannes Lions International Festival of Creativity, the most prestigious international award for creativity. The